Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Hong Yan

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
The Oncologist|January 28, 2017
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung CancerZhong-Yi Dong, Hao-Ran Zhai, Qing-Yi Hou, et al.
Cancer Medicine|June 15, 2022
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patientsHong-Xia Tian, Zhi-Hong Chen, Guang-Ling Jie, et al.
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancerXiao-Yan Bai, Jia-Ying Lin, Xu-Chao Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2026
Prognostic impact and treatment options for EGFR-mutant non-small cell lung cancer with concurrent EGFR amplificationLin-Xi Yin, Zi-Jian Huang, Lv Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
A clinical model to estimate the pretest probability of lung cancer, based on 1198 pedigrees in ChinaHuan Lin, Wen-Zhao Zhong, Xue-Ning Yang, et al.
Cancer Treatment and Research Communications|January 1, 2021
Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancerXue-Tao Li, Jia-Tao Zhang, Hong-Hong Yan, et al.
Clinical Lung Cancer|July 28, 2016
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung CancerHong-Fei Gao, An-Na Li, Jin-Ji Yang, et al.
Clinical and Translational Medicine|May 13, 2024
Genotyping of RB1 status identifies two distinct subtypes in EGFR-mutant lung cancers with SCLC transformationJie Huang, Shi-Ling Zhang, Chao Zhang, et al.
Journal of Thoracic Disease|August 30, 2019
Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based studyTao Zhang, Jia-Tao Zhang, Wen-Feng Li, et al.
Chinese Journal of Cancer|May 15, 2014
Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assayJian Su, Xu-Chao Zhang, She-Juan An, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
The Oncologist|January 28, 2017
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung CancerZhong-Yi Dong, Hao-Ran Zhai, Qing-Yi Hou, et al.
Cancer Medicine|June 15, 2022
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patientsHong-Xia Tian, Zhi-Hong Chen, Guang-Ling Jie, et al.
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancerXiao-Yan Bai, Jia-Ying Lin, Xu-Chao Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2026
Prognostic impact and treatment options for EGFR-mutant non-small cell lung cancer with concurrent EGFR amplificationLin-Xi Yin, Zi-Jian Huang, Lv Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
A clinical model to estimate the pretest probability of lung cancer, based on 1198 pedigrees in ChinaHuan Lin, Wen-Zhao Zhong, Xue-Ning Yang, et al.
Cancer Treatment and Research Communications|January 1, 2021
Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancerXue-Tao Li, Jia-Tao Zhang, Hong-Hong Yan, et al.
Clinical Lung Cancer|July 28, 2016
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung CancerHong-Fei Gao, An-Na Li, Jin-Ji Yang, et al.
Clinical and Translational Medicine|May 13, 2024
Genotyping of RB1 status identifies two distinct subtypes in EGFR-mutant lung cancers with SCLC transformationJie Huang, Shi-Ling Zhang, Chao Zhang, et al.
Journal of Thoracic Disease|August 30, 2019
Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based studyTao Zhang, Jia-Tao Zhang, Wen-Feng Li, et al.
Chinese Journal of Cancer|May 15, 2014
Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assayJian Su, Xu-Chao Zhang, She-Juan An, et al.
Pageof 12